Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients

This study has been completed.
Sponsor:
Information provided by:
Sanofi
ClinicalTrials.gov Identifier:
NCT00042354
First received: July 26, 2002
Last updated: March 4, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2004
  Estimated Primary Completion Date: No date given